Patents Assigned to Arrakis Therapeutics, Inc.
  • Nucleic acid-binding photoprobes and uses thereof
    Patent number: 11807623
    Abstract: The present invention relates to photoactivatable compounds and methods of use thereof for determining binding site and other structural information about RNA transcripts. The invention also provides methods of identifying RNA transcripts that bind compounds and are thus druggable, methods of screening drug candidates, and methods of determining drug binding sites and/or accessible or reactive sites on a target RNA.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: November 7, 2023
    Assignee: Arrakis Therapeutics, Inc.
    Inventors: Gnanasambandam Kumaravel, Jennifer C. Petter, Jonathan Craig Blain, Donovan Noel Chin, Chao Fang, Herschel Mukherjee, Neil Kubica
  • COMPOUNDS AND METHODS FOR MODULATING RNA FUNCTION
    Publication number: 20190194150
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Application
    Filed: June 30, 2017
    Publication date: June 27, 2019
    Applicant: Arrakis Therapeutics, Inc.
    Inventors: Russell C. Petter, James Gregory Barsoum, Gnanasambandam Kumaravel, Kenneth W. Bair